Medical Marijuana, Inc. Announces Q1 2018 as the Largest Sales Revenue Quarter in Company History: Shows Gross Revenue Increase Exceeding 190%

Medical Marijuana, Inc. Announces Q1 2018 as the Largest Sales Revenue Quarter in Company History: Shows Gross Revenue Increase Exceeding 190%

SAN DIEGO, May 23, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the company and its subsidiaries Kannaway® and HempMeds® have booked their largest-ever sales revenue quarter in their history in Q1 2018, as well as reached major milestones in its business operations.

Medical Marijuana, Inc. Q1 2018 revenues exceeded $10.5 million, an increase of more than 190% over Q1 2017.

Total gross profits for Q1 2018 increased more than 30% as compared to Q1 2017.

Wholly-owned subsidiary Kannaway® saw the most growth from Q1 2017 to Q1 2018, with Q1 2018 revenues increasing more than 325% to $7.5 million.

The company experienced many accomplishments in Q1 including launching its newest subsidiary Phyto Animal Health, which produces and distributes cannabidiol (CBD) and hemp products for companion animals; achieving registration of its Real Scientific Hemp Oil-X™ (RSHO-X™) and RSHO™-Blue Label products as medicines by Paraguay’s national health regulation organization (Dirección Nacional de Vigilancia Sanitaria); and being named a “Top Three Hemp Producer of 2018.”

“In Q1 2018, we had the best revenue quarter in the history of our Company,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We’re excited that, with the help of our investors, spokespeople and customers, we’ve experienced tremendous growth and the company is positioned well for continued explosive expansion.”

Medical Marijuana, Inc. also garnered positive news coverage in several national and international publications including TMZ Entertainment, Reuters, FOXNews.com, CBS’ The Doctors, The Washington Post, The Street, POPSUGAR, Epicurious and more.

“This achievement showcases that Medical Marijuana, Inc. and its subsidiaries are flourishing in the fast-growing cannabis industry and will continue to be leaders in the CBD and hemp product markets,” said Medical Marijuana, Inc. COO Blake Schroeder. “Kannaway is one example of how the company’s operations are growing internationally and helping the company increase its consumer base rapidly.”

FIRST QUARTER 2018 HIGHLIGHTS

During the first quarter of 2018, Medical Marijuana, Inc. and its subsidiaries achieved the following milestones and significant events:

1) HempMeds®

Medical Marijuana, Inc.’s wholly owned subsidiary HempMeds® is the portfolio’s predominate consumer brand and saw massive expansion and continued growth for its line of CBD hemp oil products, including the following:

    • Liz Carmouche, first female and first gay UFC fighter, became a spokesperson for the company
    • Chief Marketing Officer Stephen Jones was promoted to HempMeds® President
    • HempMeds® Mexico President Raul Elizalde was promoted to HempMeds® President, Latin America
    • HempMeds® Brasil hosted the first-ever hospital cannabis events on the benefits of CBD and provided CBD for a university study in Brazil

2) Kannaway®

Medical Marijuana, Inc.’s wholly owned subsidiary Kannaway® is the Company’s premier lifestyle marketing brand and is the fastest-growing company in the direct-selling cannabis space with an exponential growth outlook for the future. The company experienced significant milestones including the following:

    • The company achieved sequential largest revenue months ever in January, February and March
    • In Europe, the company continued to flourish with an increased number of Brand Ambassadors and announced Ali Boukhatem as Director of France

FIRST QUARTER 2018 FINANCIAL RESULTS

Gross Revenue ($ in millions):

Q1 2017 – $3.6

Q1 2018 – $10.5

Gross Profit:

Q1 2017 – $2.5

Q1 2018 – $3.3

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:

Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

andrew.hard@cmwmedia.com

www.cmwmedia.com

The post Medical Marijuana, Inc. Announces Q1 2018 as the Largest Sales Revenue Quarter in Company History: Shows Gross Revenue Increase Exceeding 190% appeared first on Medical Marijuana, Inc..

Medical Marijuana, Inc. Announces Q1 2018 as the Largest Sales Revenue Quarter in Company History: Shows Gross Revenue Increase Exceeding 190% was posted on medical marijuana inc.

Medical Marijuana, Inc. and Subsidiaries Announce April 2018 as the Largest Revenue Sales Month in Company History

Medical Marijuana, Inc. and Subsidiaries Announce April 2018 as the Largest Revenue Sales Month in Company History

SAN DIEGO, May 3, 2018  — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that both the Company and its subsidiary Kannaway®, have booked their largest-ever (unaudited) sales revenue in their history in April of 2018, as well as reached major milestones in business operations. Medical Marijuana, Inc. subsidiary HempMeds® had its largest (unaudited) sales revenue month since August of 2014.

“We’re excited to announce that April 2018 was the largest revenue month in the history of our Company,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We’re experiencing tremendous momentum for our entire portfolio of companies and look forward to building upon our success in May.”

Medical Marijuana, Inc. experienced many accomplishments in April 2018 including subsidiary HempMeds® exhibiting at the 2018 World Medical Cannabis Conference and releasing a new Active Relief Roll-On product, its subsidiary Kannaway® hosting its largest national convention in company history and releasing several new products and services, and the Company obtaining positive news coverage in several national and international publications including Men’s Health, GQ, Forbes, HelloGiggles, Nylon and Equinox’s Furthermore Magazine.

“This achievement further demonstrates that Medical Marijuana, Inc. and its subsidiaries will continue to be leaders in the cannabis industry,” said Medical Marijuana, Inc. COO Blake Schroeder. “In addition to staying abreast of cannabis legislation and scientific studies, we’re constantly exploring the needs of our customers and working to continue providing the highest quality products.”

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:

Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

andrew.hard@cmwmedia.com

www.cmwmedia.com

The post Medical Marijuana, Inc. and Subsidiaries Announce April 2018 as the Largest Revenue Sales Month in Company History appeared first on Medical Marijuana, Inc..

Medical Marijuana, Inc. and Subsidiaries Announce April 2018 as the Largest Revenue Sales Month in Company History was posted on medical marijuana inc.

Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New Hempy’s® Brand, Including New Responsibly Sourced Hemp Clothing, Products and Accessories

Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New Hempy’s® Brand, Including New Responsibly Sourced Hemp Clothing, Products and Accessories

SAN DIEGO, April 24, 2018 — Medical Marijuana, Inc. (OTC:MJNA), announced today that subsidiary Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has announced a new product line featuring Hempy’s® brand of Responsibly Sourced Hemp Clothing and Accessories.  The new line is now available for purchase in Kannaway®’s online store.

“We are excited to be able to offer the Hempy’s brand experience to Kannaway customers,” said Kannaway® CEO Blake Schroeder. “These products are fashionable, sustainably made and durable, three qualities that make for easy, long-lasting use.”

Hempy’s® products are for the environmentally conscious consumer and are created by using responsibly sourced hemp and organic cotton textiles. Available Hempy’s® hemp products include:

  • Hemp Beanies and Hats
  • Hemp Belts
  • Hemp Wallets
  • Hemp Shirts
  • Hemp Jeans
  • Hemp Lip Balm
  • Hemp Candles

“The great thing about hemp clothing is the number of advantages it has over traditional clothing fabrics. Not only does it have a soft feel but it is so durable that it tends to last for a long time,” said Hempy’s® owner Kenneth Smith. “Since hemp has more than 50,000 uses, we at Hempy’s® are happy to continue working with the Kannaway® distribution network to educate the consumer and bring these products to a larger market.”

Shop the entire line of Hempy’s® hemp clothing and accessories in the Kannaway® online store.

About Hempy’s®

Hempy’s®, founded in 1995, is one of the oldest hemp consumer goods manufacturing companies in the United States. It has grown into one of the best known and most admired hemp brands in the country.  Hempy’s® is known both domestically and internationally for its quality, long lasting, well-made goods. Hempy’s® currently has over 200 active wholesale accounts with eco-friendly retailers who carry their goods.

About Kannaway, LLC

Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here.

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:

Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

P. 858-264-6600

andrew.hard@cmwmedia.com

www.cmwmedia.com

The post Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New Hempy’s® Brand, Including New Responsibly Sourced Hemp Clothing, Products and Accessories appeared first on Medical Marijuana, Inc..

Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New Hempy’s® Brand, Including New Responsibly Sourced Hemp Clothing, Products and Accessories was posted on medical marijuana inc.

This 4/20 Give Back to the Marijuana Legalization Movement

This 4/20 Give Back to the Marijuana Legalization Movement

Celebrate 4/20 this year by doing your part to help spread legal access to medical and recreational cannabis to everyone in the U.S.

The 4/20 holiday is upon us, and once again, cannabis enthusiasts of all interest levels are looking to celebrate what has become the most important day of the year for the cannabis industry.

While twenty nine states have passed comprehensive medical marijuana programs and nine have legalized the recreational use of marijuana for adults, many Americans still find themselves on the outside of marijuana legalization looking in.

That’s why, whether you live in a legal marijuana state or are still working locally for cannabis reform, it is important to put in the effort necessary to support legalization efforts across the country.

While you are celebrating this 4/20, make sure you take at least a moment and do something to help spread marijuana legalization benefits to everyone.

Get Informed

The first step toward becoming a cannabis advocate is to get informed on the issue. If you can effectively communicate the reasons to end marijuana prohibition, then you are more likely to change the minds of others.

Our Medical Marijuana, Inc. news page will help you start learning about the cannabis industry and legalization, including changes to marijuana policy, shifts in public opinion, results of marijuana research, and more.

marijuana laws

Contact Lawmakers

Local, state, and national legislators have the ability to alter the cannabis policy in our country by creating new marijuana laws and regulations. Writing your legislators is a great way to demonstrate your support for cannabis reform and encourage them to act on behalf of their voting constituents.

The Marijuana Policy Project has a handy online tool that will help you find your legislators based on your zip code. Get started here contacting your government leaders.

If your lawmakers won’t take action on cannabis legalization, get out and vote for someone who will.

marijuana 420 rallies

Join Forces

There is strength in numbers, especially when trying to enact change in our country. Find like minded individuals either locally or nationally and pool your forces to help the fight for cannabis legalization.

Not sure where to start? These nonprofits are great places to start learning about efforts to legalize cannabis, such as letter writing campaigns, rallies and marches, and more.

Begin Today

Don’t wait to do your part. Join the fight for legal cannabis this 4/20 by getting involved and furthering the conversation regarding the benefits of cannabis. You can learn more about cannabis and the quickly expanding legalization movement on our news feed.

The post This 4/20 Give Back to the Marijuana Legalization Movement appeared first on Medical Marijuana, Inc..

This 4/20 Give Back to the Marijuana Legalization Movement was posted on medical marijuana inc.

Medical Marijuana, Inc. Reports Fourth Quarter and Year End 2017 Financial Results and Operational Highlights – Annual Revenue Increased 230% Over 2016

Medical Marijuana, Inc. Reports Fourth Quarter and Year End 2017 Financial Results and Operational Highlights – Annual Revenue Increased 230% Over 2016

SAN DIEGO, April 18, 2018 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, today announced financial results for the quarter and year ending December 31, 2017 and provided an overview of recent operational highlights.

The Company continued to show strong growth throughout the year, as 2017 revenue increased to over $26.5 million, an increase of more than 230% over 2016. Quarterly revenue for Q4 2017 grew to more than $9.4 million, an increase of more than 250% over Q4 2016 and a sequential increase over Q3 2017 of 17%.

Additionally, Medical Marijuana, Inc. subsidiary Kannaway® experienced significant growth with 2017 revenue of $15.9 million, an increase of nearly 270% over 2016.

“2017 was a historic year for cannabis legalization across the United States and the world and Medical Marijuana Inc. is proud to be on the forefront of groundbreaking industry lines,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “It is clear that the botanical and pharmaceutical side of cannabis is here to stay, which strengthens our belief in our long-term plans to continue to build shareholder value.”

Titus continued, “Medical Marijuana, Inc. and its subsidiaries experienced substantial growth in 2017, breaking record after record in sales achievements. Our leadership teams have expanded greatly including international growth in Europe, Brazil, and Mexico. We feel that we are in a great position for even more growth in 2018.”

Fourth Quarter and 2017 Highlights

During 2017, Medical Marijuana, Inc. and its subsidiaries achieved the following milestones and significant events:

1)  HempMeds®

Medical Marijuana, Inc.’s wholly-owned subsidiary HempMeds® is the portfolio’s predominate consumer brand and saw a year of massive expansion and continued growth for its line of cannabidiol (CBD) hemp oil products, including the following:

  • HempMeds® Brazil began the process of importing its Real Scientific Hemp Oil™ (RSHO™) Green Label into Brazil as the first company to offer legal medical cannabis products in the country.
  • HempMeds® Mexico inaugurated its first office in Monterrey, Nuevo Leon, Mexico, as demand continued to grow for the Company’s zero-Tetrahidrocannabidiol (THC) Real Scientific Hemp Oil-X™ (RSHO-X™) across the Country.
  • Medical Marijuana, Inc. announced that a recent clinical study conducted by renowned Mexico neurologist Dr. Carlos G. Aguirre-Velazquez successfully utilized the Company’s Real Scientific Hemp Oil-X™ (RSHO-X™) product.
  • HempMeds® Mexico President Raul Elizalde spoke to the World Health Organization and helped influence the organization’s expert recommendation not to schedule CBD as a drug.

2)  Kannaway®

Medical Marijuana, Inc.’s wholly owned subsidiary Kannaway® is the Company’s premier lifestyle marketing brand and is the fastest-growing company in the direct-selling cannabis space with an exponential growth outlook for the future. 2017 revenue increased by nearly 270% year over year. In addition to the substantial increase in revenue, Kannaway® achieved the following milestones:

  • Kannaway® expanded full business operations into the European marketplace using European-sourced materials and became capable of distribution to all citizens of European Union (EU) member nations, as well as other countries outside of the EU.
  • Kannaway® unveiled several new products throughout the year, including:
    • A renewed line of chewable energy supplements meant to enhance and energize.
    • Kannaway® Essential Oils under its line of lifestyle products.
    • A vaporizer cartridge loaded with 100 mg of pure CBD hemp oil and terpenes under its HempVAP® product line.
    • A new full-spectrum hemp oil product Kannaway® Premium Hemp Oil Liquid.
    • Kannaway® Pure Gold, a full-spectrum hemp oil that provides all the benefits of hemp without the presence of THC.
    • Kannaway® SuperGreens.
    • Hempy’s® brand of Responsibly Sourced Hemp Clothing and Accessories.

Medical Marijuana, Inc. subsidiary Kannaway® is the fastest-growing company in the direct-selling cannabis space with an exponential growth outlook for the future.

INDUSTRY HIGHLIGHTS

Medical Marijuana, Inc. was pleased to see legislative reform in the past year in the cannabis industry. Some of these highlights include:

  • A total of 29 states and the District of Columbia passed some type of medical marijuana legislation during 2017.
  • Puerto Rico opened its first medical marijuana dispensaries at the start of 2017, making it the second Caribbean entity, after Jamaica, to legalize medical marijuana.
  • California, Massachusetts, Maine and Nevada all passed measures legalizing recreational marijuana for adults 21 years of age or older.
  • The industry took in nearly $9 billion in sales in the US in 2017 and employed 121,000 people.
  • Between 20,000 and 28,000 cannabis businesses were in operation in the US by the end of 2017.
  • Canada spent $5.7 billion on medicinal cannabis in 2017 and announced recreational sales will begin in 2018.
  • Peru legalized medicinal marijuana nationwide, making it the newest addition to more than 20 nations where marijuana laws have been expanded.

FOURTH QUARTER AND YEAR-END 2016 FINANCIAL RESULTS

Annual Revenue: For the year ending December 31, 2016, Medical Marijuana, Inc. reported revenue of $26.5 million from sales of the Company’s products, as compared to revenue of $8.0 million for the year that ended December 31, 2016.

Quarterly Revenue: Revenue increased each and every quarter in 2017.

Q1 Revenue: $3.6 million

Q2 Revenue: $5.7 million

Q3 Revenue: $7.8 million

Q4 Revenue: $9.4 million

Record Q4 2017 Sales of $9,423,761 an increase of 269% compared to Q4 2016

Record Q4 2017 Gross Profit of $6,733,645 an increase of 386% compared to Q4 2016

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:

Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

P. 858-264-6600

andrew.hard@cmwmedia.com

www.cmwmedia.com

The post Medical Marijuana, Inc. Reports Fourth Quarter and Year End 2017 Financial Results and Operational Highlights – Annual Revenue Increased 230% Over 2016 appeared first on Medical Marijuana, Inc..

Medical Marijuana, Inc. Reports Fourth Quarter and Year End 2017 Financial Results and Operational Highlights – Annual Revenue Increased 230% Over 2016 was posted on medical marijuana inc.

Cannabis News Highlights
Get Free Weekly News

Subscribe and get the best cannabis news of the week delivered directly to you.

Thank you for subscribing.

Something went wrong.